IFNL3 and steatosis: Similarly when evaluating liver biopsies from HCV genotype 3 infected patients, IL28B genetic variants that otherwise are linked with more favorable therapeutic outcome were associated with more pronounced inflammation, steatosis, and fibrosis [27], [28], [29].